Clinical Trial: A single-arm, multi-center, phase II clinical study exploring the first-line treatment of advanced undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma patients with apalolitovolrelimab combined with AI chemotherapy (China)

China, Aug. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A single-arm, multi-center, phase II clinical study exploring the first-line treatment of advanced undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma patients with apalolitovolrelimab combined with AI chemotherapy'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129927

Registration Time: 2026/08/11

Type: Interventional study

Primary Sponsor: Fudan University Shanghai Cancer Center

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=333106

Published by HT Digital Content Services with permission from Health Daily Digest....